ACADIA Pharmaceuticals Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Acadia Pharma (ACAD) Misses Q1 EPS by 9c
May 7, 2020 4:44 PM EDTAcadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.57), $0.09 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $90.1 million versus the consensus estimate of $91.51 million.
ACADIA entered 2020 with positive momentum. Successful execution of our commercial efforts led to continued strong... More
